Hiscox protects higher education institutions against

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Hiscox protects higher education institutions against increased risks

NEW YORK, April 8, 2014 (GLOBE NEWSWIRE) -- Hiscox, the international specialist insurer, today announced expanded protections in their suite of insurance coverages for higher education institutions. Colleges and universities are facing a growing array of risks, and courts have recently found more institutions across the US liable for violations under the Clery Act, Title IX and other laws and regulations. Hiscox coverage protects colleges, universities and their employees from the specific risks faced by higher education institutions, including the failure to educate, tenure/promotion decisions and the exposure of private data.

The Clery Act is one area where higher education institutions are increasingly being cited for neglecting their responsibility to inform students about acts of harassment, campus crime and other potential dangers to their well being. Enforcement of this act has increased exponentially in recent years with fines of $35,000 for each violation.  In 2013, the US Department of Education issued $1,455,000 in fines for Clery Act violations – nearly equal to the $1,650,000 issued in the prior 22 years combined.  Hiscox's Higher Education Portfolio covers costs associated with both Clery Act investigations and violation claims.

"The exposures of higher education institutions continue to increase, and our coverage has adapted to cover both traditional and new perils," said Bertrand Spunberg, Senior Vice President, Practice Leader – Executive Risk for Hiscox USA.  "Hiscox provides the specific protections colleges and universities need for exposures related to their students and staff whether they are on campus, online or studying abroad."

Hiscox Educators Legal Liability policies provide coverage for common liability claims including the failure to educate, failure to grant due process regarding disciplinary matters, discrimination and reputational risks associated with campus violence. Hiscox policy endorsements also cover higher education institutions for data breach/privacy exposures related to medical and financial records and the associated reputation loss. Ensuring the safety of students travelling abroad and protecting against employee theft are additional exposures Hiscox covers through Special Protection Solutions and Crime/Fiduciary endorsements.

In the US, Hiscox provides Executive Risk insurance coverage, including specialized policies for Higher Education risks, along with a diverse portfolio of professional liability and other commercial insurance to US domiciled entities. Hiscox has US offices in New York, NY; Atlanta, GA; Chicago, IL; Los Angeles, CA; San Francisco, CA and White Plains, NY.

Additional information can be found at www.hiscoxbroker.com

Follow Hiscox USA on Twitter @Hiscox_USA .

For further information please contact:

Hunter Hoffmann
646-442-8341
hunter.hoffmann@hiscox.com

Kate Dillon
203-254-1300 x115
kdillon@prosek.com

About Hiscox in the U.S.

Hiscox, the international specialist insurer, is headquartered in Bermuda and listed on the London Stock Exchange (LSE: HSX ). There are three main underwriting parts of the Group – Hiscox London Market, Hiscox UK and Europe and Hiscox International. Hiscox International includes operations in Bermuda, Guernsey and the USA.  Hiscox Syndicates Ltd is authorized by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and Prudential Regulation Authority. The ability of syndicates at Lloyd's to do business in the USA, and its territories, is restricted as they are not US-based insurers. Hiscox Underwriting Limited and Hiscox ASM Limited are authorized and regulated by the Financial Conduct Authority.

Hiscox Inc., a Delaware corporation headquartered in New York, d/b/a Hiscox Insurance Agency in CA, is a licensed insurance intermediary for admitted and surplus lines business. Hiscox Inc. underwrites on behalf of, and places business with, Hiscox Insurance Company Inc., other domestic insurers, and syndicates at Lloyd's ( www.lloyds.com ). Hiscox Insurance Company Inc. is a Chicago, IL domiciled insurer which is admitted or licensed to do business in all 50 states and the District of Columbia.

Hunter Hoffmann,646-442-8341 Kate Dillon, 203-254-1300 x115

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 248

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 34

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 497

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 17

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 336

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 81

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 62

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 83

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 281

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 493

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading

Top 5 Most Recently Viewed Articles

FPI Earnings Preview: Traders Eye EPS and Guidance Impact

Updated Category News Views 158

Farmland Partners (NYSE:FPI) is prepped to drop its quarterly earnings on February 18, 2026, and you better believe traders are already sweating over it. Analysts are throwing out estimates pegging the earnings per share (EPS) at $0.19—now, that's not exactly a home run but it's enough to keep eyes glued to the screens as we await the news. The buzz in the air is thick;...

Continue Reading
Reviva Pharmaceuticals Engages Investors at 2025 Summit

Updated Category News Views 312

Reviva Pharmaceuticals Attending the 2025 Investor Healthcare Summit Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) is a leader in the biopharmaceutical industry, committed to developing cutting-edge therapies that cater to unmet medical needs. This January, Reviva will have an influential presence at the upcoming Lytham Partners 2025 Investor Healthcare Summit....

Continue Reading
Genpact's Q1 2025 Financial Highlights and Future Outlook

Updated Category News Views 886

Financial Performance Overview for Genpact Genpact Limited (NYSE: G) has reported outstanding net revenues of $1.215 billion for the first quarter of 2025, reflecting a robust growth rate of 7.4% year-over-year, or 8.3% when adjusted for constant currency fluctuations. This growth has been fueled by an impressive performance in its Data-Tech-AI segment, which generated...

Continue Reading
Multinational Investments: How to Reach More Countries

Updated Category Investing Views 706

Global expansion has become a strategic priority for companies seeking long-term growth. Markets mature, local competition intensifies, and consumer expectations evolve quickly. As a result, multinational investments are no longer reserved for massive corporations. Mid-sized and even smaller firms are exploring foreign markets to diversify revenue and increase resilience....

Continue Reading
Nobu Hospitality Unveils Luxury Residential Options in Kraków

Updated Category News Views 126

Nobu Hospitality Expands Its Luxury Footprint Nobu Hospitality is a name synonymous with luxury and refinement in the hospitality industry, expanding its prestigious brand into new territories. One of its latest ventures takes a significant leap into a magnificent city rich in history—Kraków. This development marks a notable milestone as it is Nobu's first residential...

Continue Reading